These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4197837)

  • 41. [Clotting factors and the process of cellular excitation].
    Rusiaev VF; Kuznik BI
    Usp Fiziol Nauk; 1977; 8(2):94-111. PubMed ID: 899186
    [No Abstract]   [Full Text] [Related]  

  • 42. Role of adrenergic stimulation in the fibrinolytic activation induced by histamine shock.
    Dosne AM
    Pathol Biol (Paris); 1975 Dec; 23 suppl():63-5. PubMed ID: 772560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Research on the influence of vasculo-tissue factors on coagulation and on fibrinolysis. 8. Involvement of the vessel wall in activation of the plasmatic fibrinolytic system provoked by means of administration of adrenalin in the dog].
    Neri Serneri GG; Rossi Ferrini PL; Masotti G; Silvestrini E; Paoletti P; Nocentini P; Monaci M
    G Gerontol; 1965 Jun; 13(6):551-8. PubMed ID: 5843518
    [No Abstract]   [Full Text] [Related]  

  • 44. Coagulation and fibrinolysis in blood and lymph after massive haemorrhage in dogs.
    Leandoer L
    Acta Chir Scand; 1968; 134(8):597-605. PubMed ID: 5713444
    [No Abstract]   [Full Text] [Related]  

  • 45. [Relation of the drugs acting on the blood pressure to the blood pressure and blood flow volume. 1. Nikethamide, adrenaline, noradrenaline, serotonin, histamine, acetylcholine, vasopressin, kallikrein, potassium cyanide, sodium nitrite and nitroglycerin].
    Nagasawa K; Fukuda H
    Eisei Shikenjo Hokoku; 1965 Oct; 83():32-5. PubMed ID: 4962835
    [No Abstract]   [Full Text] [Related]  

  • 46. Ionic pathways and intracellular potential.
    Trautwein W
    Arch Inst Cardiol Mex; 1977; 47(2):189-97. PubMed ID: 901054
    [No Abstract]   [Full Text] [Related]  

  • 47. [Comparative characteristics of blood and lymph clotting and fibrinolytic activity].
    Kuznik BI; Budazhabon GB; Tsybikov NN
    Fiziol Zh SSSR Im I M Sechenova; 1979 Jun; 65(6):867-71. PubMed ID: 467729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The experimental study of blood coagulation and fibrinolysis in acute portal vein occlusion].
    Nakao A
    Nihon Geka Gakkai Zasshi; 1983 Aug; 84(8):692-702. PubMed ID: 6687131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the blood clotting mechanisms in man and some common laboratory animals.
    Kase F; Pospísil J
    Acta Univ Carol Med Monogr; 1987; 119():11-22. PubMed ID: 3324727
    [No Abstract]   [Full Text] [Related]  

  • 50. Cardiohemodynamic effect of 5-methyl-7-diethyl-amino-s-triazolo-(1,5a)pyrimidine (trapymin).
    Oguro K; Taira N; Hashimoto K
    Arzneimittelforschung; 1974 Jun; 24(6):911-4. PubMed ID: 4211850
    [No Abstract]   [Full Text] [Related]  

  • 51. Nonuniformity: an important physiological modulator of the contractile performance of the normal heart.
    Brutsaert DL
    Verh K Acad Geneeskd Belg; 1985; 47(4):257-86. PubMed ID: 2934903
    [No Abstract]   [Full Text] [Related]  

  • 52. [Visceral vessel responses to stimulation of cardiac receptors].
    Zaritskiĭ GV
    Fiziol Zh SSSR Im I M Sechenova; 1968 Oct; 54(10):1171-8. PubMed ID: 5735946
    [No Abstract]   [Full Text] [Related]  

  • 53. Coagulation factors and components of the fibrinolytic system in lymph and blood in dogs.
    Leandoer L; Bergentz SE; Nilsson IM
    Thromb Diath Haemorrh; 1968 Mar; 19(1):129-35. PubMed ID: 5652223
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of clotting and of addition of histamine on its distribution in blood.
    Anrep GV; Barsoum GS; Talaat M; Wieninger E
    J Physiol; 1939 Jul; 96(2):130-8. PubMed ID: 16995121
    [No Abstract]   [Full Text] [Related]  

  • 55. [The heart as an efferent regulator of the blood clotting process and fibrinolysis].
    Kuznik BI; Al'fonsov VV; Basov VP; Tsibikov NN; Malezhik LP
    Kardiologiia; 1973 Mar; 13(3):10-7. PubMed ID: 4197837
    [No Abstract]   [Full Text] [Related]  

  • 56. The mechanism of action of vasoactive agents on the blood clotting and fibrinolysis.
    Mishchenko VP; Kuznik BI; Bochkarnikov VV
    Cor Vasa; 1972; 14(3):228-38. PubMed ID: 4629303
    [No Abstract]   [Full Text] [Related]  

  • 57. [Heart as an efferent regulator of the process of blood coagulation and fibrinolysis].
    Kuznik BI; Al'fonsov VV; Basov VP; Tsibikov NN; Malezhik LP
    Kardiologiia; 1973 Mar; 13(3):10-7. PubMed ID: 4780466
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of nitroglycerin on the discharge of blood coagulation factors by an active heart].
    Kuznik BI; Al'fonsov VV; Bochkarnikov VV; Malezhik LP
    Farmakol Toksikol; 1972; 35(1):95-8. PubMed ID: 4622160
    [No Abstract]   [Full Text] [Related]  

  • 59. [Universal mechanism for regulating blood clotting and fibrinolysis].
    Kuznik BI
    Usp Sovrem Biol; 1979; 87(1):108-24. PubMed ID: 373283
    [No Abstract]   [Full Text] [Related]  

  • 60. [Role of the heart and vessels in regulating blood coagulation and fibrinolysis].
    Kuznik BI; Mishchenko VP
    Kardiologiia; 1973 Apr; 13(4):145-54. PubMed ID: 4575995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.